News
Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...
The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...
Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!
GLP-1 receptor agonists such as semaglutide and tirzepatide have proven to be highly effective in supporting weight loss by regulating appetite and metabolism. These medications work by mimicking ...
A pill version of semaglutide—the generic name for Novo Nordisk’s diabetes drug Ozempic and its weight-loss version Wegovy—was approved by the Food and Drug Administration as a type 2 ...
A leading GP has said that people ordering illicit weight loss drugs online are "dicing with death" after a BBC investigation ...
9d
GlobalData on MSNThe GLP-1 drug shortage is over. What’s next for the compounders?Tirzepatide is sold under the brand names Mounjaro and Zepbound for T2D treatment and weight loss, respectively. Compounded ...
A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results